Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Bavarian Nordic Lands $36M for Imvamune Production

Dec. 8, 2010

By Cormac Sheridan

Basilea to Receive $130M Arbitration Award from J&J

Dec. 1, 2010

By Cormac Sheridan

Covagen Raises $6M to Fund Fynomer Scaffolds Technology

Dec. 1, 2010

By Cormac Sheridan

Basilea to Receive $130M Arbitration Award from J&J

Nov. 30, 2010

By Cormac Sheridan

Zealand Lists on Copenhagen Exchange in Scaled-Back IPO

Nov. 24, 2010

By Cormac Sheridan

Local Investors Help Clavis with $26M Private Placement

Nov. 24, 2010

By Cormac Sheridan

Paion Stock Rises Briefly on Phase IIb Remimazolam Data

Nov. 24, 2010

By Cormac Sheridan

Zealand Lists on Copenhagen Exchange in Scaled-Back IPO

Nov. 24, 2010

By Cormac Sheridan

Ireland Retains Commitment to Low Corporation Tax

Nov. 17, 2010

By Cormac Sheridan

Clavis, Clovis Extend CP-4126 Pact into Asia

Nov. 17, 2010

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...